Klaria Ab is a pharmaceutical company based in Uppsala that specializes in the development of new pharmaceuticals utilizing alginate film technology. The company focuses on creating innovative drug delivery systems, particularly through the use of alginate-based films designed for administration via the oral mucosa. This approach aims to enhance the effectiveness of medication delivery and improve patient outcomes.
The company's research and development efforts are concentrated on therapeutic areas that offer significant value to patients. Klaria Ab has a diverse pipeline that includes various drug formulations, reflecting its commitment to advancing healthcare through technological innovation. The company collaborates with healthcare professionals and researchers to explore potential applications of its products, including in emergency medicine, such as the delivery of adrenaline.
Klaria Ab's strategic emphasis on improving healthcare outcomes positions it as a contributor to the evolving landscape of pharmaceutical solutions, particularly in the realm of advanced drug delivery systems.